Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

webmd.com

1 of 0

Resource Description:

The FDA has approved the human papillomavirus (HPV) vaccine Cervarix for use in girls and young women ages 10-25 to help prevent cervical cancer.

« Back to the GSK Receives FDA Approval for Cervarix Vaccine in Girls and Young Women WisdomCard

TrustedWisdom on

Expert review of this website

Related Health Centers:

Advertisement